AstraZeneca buys cell therapy biotech in up to $1bn deal
London-listed pharmaceuticals group expands investments in cancer cell therapies with EsoBiotec acquisition
Full Article
AstraZeneca buys cell therapy biotech in up to $1bn deal
FT.com
0 shares
1 views